Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Laurence O. Watkins"'
Autor:
Ola Akinboboye, Brenda Jamerson, Luther T. Clark, Adam B. Polis, Mary Elmer, Christine Pierre, Millicent Gorham, Gary Puckrein, Jeanne M. Regnante, Ileana L. Piña, Laurence O. Watkins, Cassandra McCullough
Publikováno v:
Current problems in cardiology. 44(5)
Clinical trial results provide the critical evidence base for evaluating the safety and efficacy of new medicines and medical products. Efficacy and safety may differ among population subgroups depending on intrinsic/extrinsic factors, including sex,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dd5adfa0927487f6acdfd7ce0ff1471
https://pubmed.ncbi.nlm.nih.gov/32723500
https://pubmed.ncbi.nlm.nih.gov/32723500
Autor:
James R. Gavin, Jackson T. Wright, Elijah Saunders, Judith E. Mitchell, James W. Reed, Karol E. Watson, Laurence O. Watkins, Keith C. Ferdinand, Nanette K. Wenger, John M. Flack
Publikováno v:
Journal of the National Medical Association. 103:86-98
Advances in heart failure treatment have not necessarily translated into equity in improved outcomes for African Americans. Heart failure in African Americans is characterized by a higher prevalence, especially at younger ages; more-adverse course wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aeea863a97584e668f6e73b5edebfc3e
https://doi.org/10.1016/s0027-9684(15)30257-1
https://doi.org/10.1016/s0027-9684(15)30257-1
Autor:
Laurence O. Watkins, Athanassios N. Chremos, Harold W. Schnaper, Alexandra Langendorfer, Michael L Prisant, Reagan H. Bradford, Maria Downton
Publikováno v:
The American Journal of Cardiology. 78:420-424
A paucity of substantive data from clinical drug trials is available specifically evaluating the effects of therapy for hypercholesterolemia in African-Americans, even though a substantial number are candidates for medical advice and intervention for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28555bdb26dbee5d7d63fc14c68cd607
https://doi.org/10.1016/s0002-9149(96)00330-x
https://doi.org/10.1016/s0002-9149(96)00330-x
Autor:
Laurence O. Watkins
Coronary heart disease (CHD) is the leading cause of death in the United States. The rate of CHD and CHD death varies across racial groups, with higher rates among black men and women than among white men and women. The development of CHD is promoted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75d9caf33dcb6409f9f9eb380859b41f
https://europepmc.org/articles/PMC6654722/
https://europepmc.org/articles/PMC6654722/
Autor:
Elijah Saunders, Laurence O. Watkins, Nanette K. Wenger, James W. Reed, Luther T. Clark, Keith C. Ferdinand, John M. Flack, Shiriki K. Kumanyika, James R. Gavin, Jackson T. Wright, Karol E. Watson, Ella W. Horton, W. Dallas Hall
Publikováno v:
Disease management : DM. 9(1)
The National Cholesterol Education Program defines the metabolic syndrome as three or more of five abnormalities: waist circumference of40 in (102 cm) for men or35 in (88 cm) for women, triglyceride level ofor =150 mg/dL, high-density lipoprotein cho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::122ef7ec0225ff974a6c6a6f9910fc76
https://pubmed.ncbi.nlm.nih.gov/16466339
https://pubmed.ncbi.nlm.nih.gov/16466339
Autor:
Laurence O, Watkins
Publikováno v:
Reviews in cardiovascular medicine. 5
Coronary heart disease (CHD) is the leading cause of death in African Americans. CHD mortality rates have not declined in recent years as much as they did from 1970 to 1990. Significant mortality rate variations exist related to regional, socioeconom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::198d0b414fb3b6e99d415c4f0ca6a439
https://pubmed.ncbi.nlm.nih.gov/15303080
https://pubmed.ncbi.nlm.nih.gov/15303080
Autor:
L. Michael Prisant, Martin J. Frank, Steven L. Russell, Laurence O. Watkins, Mark S. Smith, Roger L. Manwaring, Abdulla M. Abdulla
Publikováno v:
Journal of clinical pharmacology. 31(3)
The efficacy of mexiletine and quinidine in controlling ventricular couplets (VC) and ventricular tachycardia (VT) was compared in 156 trials (78 for each drug) in 114 consecutive patients. Forty-two patients received both drugs, whereas 36 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9b3c945c62db7b1258f220837dcaba4
https://pubmed.ncbi.nlm.nih.gov/2019663
https://pubmed.ncbi.nlm.nih.gov/2019663
Autor:
William B. Strong, Laurence O. Watkins
Publikováno v:
Current Problems in Pediatrics. 14:7-63
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1758c81ad7e5860ba0ff49353c2ff54e
https://doi.org/10.1016/0045-9380(84)90035-5
https://doi.org/10.1016/0045-9380(84)90035-5
Autor:
Martin J. Frank, Miltiadis A. Stefadouros, Laurence O. Watkins, Abdulla M. Abdulla, L. Michael Prisant
Publikováno v:
The American Journal of Cardiology. 53:1608-1613
The prevalence of potentially lethal arrhythmias (PLA) in groups of patients with hypertrophic cardiomyopathy has been assessed, but the rate at which they develop (their incidence) during long-term follow-up has not been reported. Therefore, conduct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73cf8be94b17ac3b569f599940ef89f1
https://doi.org/10.1016/0002-9149(84)90588-5
https://doi.org/10.1016/0002-9149(84)90588-5
Autor:
Martin J. Frank, Laurence O. Watkins, Miltiadis A. Stefadouros, Abdulla M. Abdulla, L M Prisant
Publikováno v:
European Heart Journal. 4:235-243
Potentially lethal arrhythmias (PLA) are common in hypertrophic cardiomyopathies and are implicated in sudden death. We have demonstrated that propranolol is effective in controlling symptoms, but have not previously evaluated its effect on PLA. Our
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a4ea6bf228ed0660e56ab4e87bebb6d
https://doi.org/10.1093/eurheartj/4.suppl_f.235
https://doi.org/10.1093/eurheartj/4.suppl_f.235